Circulating biomarkers in chronic thromboembolic pulmonary hypertension. (1st June 2019)

• Record Type: Journal Article
• Authors: Zhang, Meng; Zhang, Yunxia; Pang, Wenyi; Zhai, Zhenguo; Wang, Chen
• Is Part Of: Pulmonary circulation. Volume 9:Number 2(2019)
• Page Start: 1
• Page End: 13
• Publication Date: 2019-06-01
• Subjects: Chronic thromboembolic pulmonary hypertension (CTEPH) -- biomarker -- prognosis -- diagnosis; Pulmonary circulation -- Periodicals; Pulmonary circulation; Electronic journals -- Sciences; Periodicals; 616.24005
• DOI: 10.1177/2045894019844480
• Languages: English
• ISSNs: 2045-8932

Abstract

Abstract : Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious condition characterized with chronic organized thrombi that obstruct the pulmonary vessels, leading to pulmonary hypertension (PH) and ultimately right heart failure. Although CTEPH is the only form of PH that can be cured with surgical intervention, not all patients with CTEPH will be deemed operable. Some CTEPH patients still have a poor prognosis. Therefore, the determination of diagnostic and prognostic biomarkers of CTEPH is of great importance for the early intervention to improve prognosis of patients with CTEPH. Several markers related to multiple mechanisms of CTEPH have been recently identified as circulating diagnostic and prognostic biomarkers in these patients. However, the existing literature review of biomarkers of CTEPH is relatively sparse. In this article, we review recent advances in circulating biomarkers of CTEPH and describe future applications of these biomarkers in the management of CTEPH.